Empagliflozin Monotherapy for 12 Weeks Improves Glycemic Control in Japanese Patients With Type 2 Diabetes (T2DM)

被引：0
|
作者：
Kadowaki, Takashi
Haneda, Masakazu
Inagaki, Nobuya
Taniguchi, Atsushi
Sakamoto, Masashi
Koiwai, Kazuki
Rattunde, Henning
Woerle, Hans J.
Broedl, Uli C.
机构：
来源：
DIABETES | 2013年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1144-P
引用
收藏
页码：A297 / A298
页数：2
相关论文
共 50 条
  • [21] Sitagliptin monotherapy improved glycemic control in the fasting and postprandial states and beta-cell function after 24 weeks in patients with type 2 diabetes (T2DM)
    Aschner, Pablo
    Kipnes, Mark
    Lunceford, Jared
    Mickel, Carolyn
    Davies, Michael
    Williams-Herman, Debora
    DIABETES, 2006, 55 : A462 - A462
  • [22] Alogliptin monotherapy improves glycemic control in patients with type 2 diabetes
    Defronzo, Ralph
    Fleck, Penny
    Wilson, Craig
    Mekki, Qais
    DIABETES, 2008, 57 : A133 - A133
  • [23] Hyperglycemia Drives Glycemic Variability in Patients with Type 2 Diabetes (T2DM)
    Olawsky, Evan A.
    Zhang, Yuan
    Alvear, Alison C.
    Eberly, Lynn E.
    Chow, Lisa S.
    DIABETES, 2020, 69
  • [24] Effect of empagliflozin (EMPA) on bone fractures in patients with type 2 diabetes (T2DM)
    Kohler, S.
    Kaspers, S.
    Salsali, A.
    Zeller, C.
    Woerle, H. -J.
    DIABETOLOGIA, 2016, 59 : S26 - S26
  • [25] Personality, Self-Management Behaviors, and Glycemic Control among Japanese Patients with Type 2 Diabetes Mellitus (T2DM)
    Morikawa, Sakiko Y.
    Fujihara, Kazuya
    Hatta, Mariko
    Takeda, Yasunaga
    Ishii, Dai
    Yachida, Junko
    Horikawa, Chika
    Kato, Mitsutoshi
    Maegawa, Hiroshi
    Sone, Hirohito
    DIABETES, 2019, 68
  • [26] GlyCemic Control with Add-On Medication Use for Patients with Type 2 Diabetes Mellitus (T2DM) Who Failed Metformin Monotherapy
    Fu, Alex Z.
    Qiu, Ying
    Radican, Larry
    DIABETES, 2010, 59 : A612 - A613
  • [27] Empagliflozin in Patients With Type 2 Diabetes Mellitus (T2DM) and Renal Impairment (RI)
    Barnett, Anthony H.
    Mithal, Ambrish
    Manassie, Jenny
    Jones, Russell
    Rattunde, Henning
    Woerle, Hans J.
    Broedl, Uli C.
    DIABETES, 2013, 62 : A286 - A286
  • [28] Addition of sitagliptin to ongoing metformin monotherapy improves glycemic control in Japanese patients with type 2 diabetes over 52weeks
    Kadowaki, Takashi
    Tajima, Naoko
    Odawara, Masato
    Nishii, Mikio
    Taniguchi, Tadaaki
    Ferreira, Juan Camilo Arjona
    JOURNAL OF DIABETES INVESTIGATION, 2013, 4 (02) : 174 - 181
  • [29] Empagliflozin (EMPA) for ≥76 Weeks as Add-on to Metformin Plus Sulfonylurea (SU) in Patients with Type 2 Diabetes (T2DM)
    Haering, Hans-Ulrich
    Merker, Ludwig
    Vedel, Anita
    Roux, Christiansen Flavien
    Salsali, Afshin
    Kim, Gabriel
    Meinicke, Thomas
    Woerle, Hans J.
    Broedl, Uli C.
    DIABETES, 2014, 63 : A280 - A280
  • [30] Are Chromium (Cr) Supplements Efficacious for Glycemic Control in Type 2 Diabetes (T2DM)?
    Dwyer, Johanna T.
    Costello, R. B.
    Bailey, R. L.
    Wambogo, E.
    FASEB JOURNAL, 2016, 30
12345